• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性转甲状腺素蛋白淀粉样变性的神经超声:危险信号和可能的进展生物标志物。

Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers.

机构信息

Department of Neurosciences, University of Padova, Via Giustiniani 5, 35128, Padova, Italy.

Padova Neuroscience Center (PNC), University of Padova, Padova, Italy.

出版信息

J Neurol. 2021 Jan;268(1):189-198. doi: 10.1007/s00415-020-10127-8. Epub 2020 Aug 4.

DOI:10.1007/s00415-020-10127-8
PMID:32749600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7815618/
Abstract

BACKGROUND

Diagnostic delay of hereditary transthyretin amyloidosis (ATTRv, v for variant) prevents timely treatment and, therefore, concurs to the mortality of the disease. The aim of the present study was to explore with nerve ultrasound (US) possible red flags for early diagnosis in ATTRv patients with carpal tunnel syndrome (CTS) and/or polyneuropathy and in pre-symptomatic carriers.

METHODS

Patients and pre-symptomatic carriers with a TTR gene mutation were enrolled from seven Italian centers. Severity of CTS was assessed with neurophysiology and clinical evaluation. Median nerve cross-section area (CSA) was measured with US in ATTRv carriers with CTS (TTR-CTS). One thousand one hundred ninety-six idiopathic CTS were used as controls. Nerve US was also performed in several nerve trunks (median, ulnar, radial, brachial plexi, tibial, peroneal, sciatic, sural) in ATTRv patients with polyneuropathy and in pre-symptomatic carriers.

RESULTS

Sixty-two subjects (34 men, 28 women, mean age 59.8 years ± 12) with TTR gene mutation were recruited. With regard to CTS, while in idiopathic CTS there was a direct correlation between CTS severity and median nerve CSA (r = 0.55, p < 0.01), in the subgroup of TTR-CTS subjects (16 subjects, 5 with bilateral CTS) CSA did not significantly correlate with CTS severity (r = - 0.473). ATTRv patients with polyneuropathy showed larger CSA than pre-symptomatic carriers in several nerve sites, more pronounced at brachial plexi (p < 0.001).

CONCLUSIONS

The present study identifies nerve morphological US patterns that may help in the early diagnosis (morpho-functional dissociation of median nerve in CTS) and monitoring of pre-symptomatic TTR carriers (larger nerve CSA at proximal nerve sites, especially at brachial plexi).

摘要

背景

遗传性转甲状腺素蛋白淀粉样变性(ATTRv,v 代表变体)的诊断延迟会导致治疗不及时,从而导致疾病的死亡率增加。本研究的目的是通过神经超声(US)探索 ATTRv 患者伴腕管综合征(CTS)和/或多发性神经病以及无症状携带者中可能有助于早期诊断的特征。

方法

从七个意大利中心招募了携带 TTR 基因突变的患者和无症状携带者。通过神经生理学和临床评估评估 CTS 的严重程度。在伴 CTS(TTR-CTS)的 ATTRv 携带者中使用 US 测量正中神经横截面积(CSA)。将 1196 例特发性 CTS 作为对照。还对伴多发性神经病的 ATTRv 患者和无症状携带者的多个神经干(正中神经、尺神经、桡神经、臂丛、胫神经、腓总神经、坐骨神经、腓肠神经)进行了神经 US 检查。

结果

共纳入 62 名患者(34 名男性,28 名女性,平均年龄 59.8±12 岁),携带 TTR 基因突变。关于 CTS,在特发性 CTS 中,CTS 严重程度与正中神经 CSA 之间存在直接相关性(r=0.55,p<0.01),而在 TTR-CTS 亚组(16 例,5 例双侧 CTS)中,CSA 与 CTS 严重程度无显著相关性(r=-0.473)。伴多发性神经病的 ATTRv 患者在多个神经部位的 CSA 大于无症状携带者,在臂丛中更为明显(p<0.001)。

结论

本研究确定了神经形态学 US 模式,这些模式可能有助于早期诊断(CTS 中正中神经的形态-功能分离)和监测无症状 TTR 携带者(近端神经部位,尤其是臂丛中的神经 CSA 更大)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1255/7815618/5958c270aa6d/415_2020_10127_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1255/7815618/86fb49c0e95c/415_2020_10127_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1255/7815618/5958c270aa6d/415_2020_10127_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1255/7815618/86fb49c0e95c/415_2020_10127_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1255/7815618/5958c270aa6d/415_2020_10127_Fig2_HTML.jpg

相似文献

1
Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers.遗传性转甲状腺素蛋白淀粉样变性的神经超声:危险信号和可能的进展生物标志物。
J Neurol. 2021 Jan;268(1):189-198. doi: 10.1007/s00415-020-10127-8. Epub 2020 Aug 4.
2
Magnetic resonance neurography and diffusion tensor imaging of the sciatic nerve in hereditary transthyretin amyloidosis polyneuropathy.遗传性转甲状腺素蛋白淀粉样变性多发性神经病的坐骨神经磁共振神经成像和弥散张量成像。
J Neurol. 2023 Oct;270(10):4827-4840. doi: 10.1007/s00415-023-11813-z. Epub 2023 Jun 17.
3
Neurological manifestations of hereditary transthyretin amyloidosis: a focus on diagnostic delays.遗传性转甲状腺素蛋白淀粉样变性的神经表现:关注诊断延迟。
Amyloid. 2022 Sep;29(3):184-189. doi: 10.1080/13506129.2022.2046557. Epub 2022 Mar 7.
4
Red flags and adjusted suspicion index for distinguishing hereditary transthyretin amyloid polyneuropathy from idiopathic axonal polyneuropathy.用于鉴别遗传性转甲状腺素蛋白淀粉样多神经病与特发性轴索性多神经病的危险信号和调整后的可疑指数。
Neurol Sci. 2023 Oct;44(10):3679-3685. doi: 10.1007/s10072-023-06859-w. Epub 2023 Jun 2.
5
Amyloid detection in the transverse carpal ligament of patients with hereditary ATTR V30M amyloidosis and carpal tunnel syndrome.遗传性 ATTR V30M 淀粉样变性伴腕管综合征患者腕横韧带中的淀粉样蛋白检测。
Amyloid. 2017 Jun;24(2):73-77. doi: 10.1080/13506129.2017.1313222. Epub 2017 Apr 16.
6
Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis.磁化传递比定量评估遗传性转甲状腺素蛋白淀粉样变性多发性神经病。
Ann Clin Transl Neurol. 2020 May;7(5):799-807. doi: 10.1002/acn3.51049. Epub 2020 Apr 25.
7
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis.遗传性转甲状腺素蛋白淀粉样变性中进行性臂丛神经肿大。
J Neurol. 2022 Apr;269(4):1905-1912. doi: 10.1007/s00415-021-10754-9. Epub 2021 Aug 19.
8
Longitudinal analysis of serum neurofilament light chain levels as marker for neuronal damage in hereditary transthyretin amyloidosis.作为转甲状腺素蛋白淀粉样变性症神经元损伤标志物的血清神经丝轻链水平的纵向分析。
Amyloid. 2024 Jun;31(2):132-141. doi: 10.1080/13506129.2024.2327342. Epub 2024 Mar 13.
9
Severity of Carpal tunnel syndrome assessed with high frequency ultrasonography.高频超声评估腕管综合征的严重程度。
Rheumatol Int. 2010 Apr;30(6):761-5. doi: 10.1007/s00296-009-1061-x. Epub 2009 Jul 11.
10
Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis.一样又不一样?野生型转甲状腺素蛋白(ATTRwt)淀粉样变的神经表现。
Amyloid. 2022 Jun;29(2):92-101. doi: 10.1080/13506129.2021.2014448. Epub 2022 Jan 7.

引用本文的文献

1
Clinical and Electrodiagnostic Correlations of Ultrasound-Detected Markedly Enlarged Median Nerve at the Wrist.超声检测到腕部正中神经明显增粗的临床与电诊断相关性
Neurol Int. 2025 Aug 7;17(8):124. doi: 10.3390/neurolint17080124.
2
Clinical differential factors in patients with hereditary transthyretin amyloidosis with Val142Ile and Ser43Asn mutations.携带Val142Ile和Ser43Asn突变的遗传性转甲状腺素蛋白淀粉样变性患者的临床鉴别因素。
Orphanet J Rare Dis. 2024 Dec 20;19(1):474. doi: 10.1186/s13023-024-03496-0.
3
Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers.

本文引用的文献

1
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation.心脏淀粉样变中的动脉血栓栓塞事件:超越心房颤动的观察。
Amyloid. 2021 Mar;28(1):12-18. doi: 10.1080/13506129.2020.1798922. Epub 2020 Sep 28.
2
Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis.对《APOLLO研究中的自主神经结局分析》的勘误,APOLLO是一项关于RNAi治疗药物帕替拉韦用于遗传性转甲状腺素蛋白介导的淀粉样变性患者的III期试验。
J Neurol. 2020 Mar;267(3):713-714. doi: 10.1007/s00415-020-09715-5.
无症状转甲状腺素蛋白突变携带者的电生理监测
Muscle Nerve. 2025 Feb;71(2):208-215. doi: 10.1002/mus.28318. Epub 2024 Dec 12.
4
[Not Available].[无可用内容]。
CMAJ. 2024 Apr 14;196(14):E501-E505. doi: 10.1503/cmaj.230671-f.
5
Hereditary transthyretin amyloidosis presenting with carpal tunnel syndrome.表现为腕管综合征的遗传性转甲状腺素蛋白淀粉样变性
CMAJ. 2024 Jan 28;196(3):E95-E99. doi: 10.1503/cmaj.230671.
6
Quantitative muscle ultrasound as a disease biomarker in hereditary transthyretin amyloidosis with polyneuropathy.定量肌肉超声作为遗传性转甲状腺素蛋白淀粉样变多发性神经病的疾病生物标志物。
Neurol Sci. 2024 Jul;45(7):3449-3459. doi: 10.1007/s10072-024-07340-y. Epub 2024 Jan 25.
7
Early detection of nerve involvement in presymptomatic TTR mutation carriers: exploring potential markers of disease onset.早期检测无症状 TTR 突变携带者的神经受累:探索疾病发作的潜在标志物。
Neurol Sci. 2024 Apr;45(4):1675-1684. doi: 10.1007/s10072-023-07177-x. Epub 2023 Nov 8.
8
Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers.详细的临床、生理和病理表型分析可能会影响转甲状腺素蛋白淀粉样变性心肌病(ATTR-CM)患者获得疾病修正治疗的机会。
J Neurol Neurosurg Psychiatry. 2024 May 14;95(6):489-499. doi: 10.1136/jnnp-2023-332180.
9
Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathy.遗传性转甲状腺素蛋白淀粉样变性:一项以周围神经病变为重点的综述
Front Neurol. 2023 Oct 5;14:1242815. doi: 10.3389/fneur.2023.1242815. eCollection 2023.
10
Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal.遗传性转甲状腺素蛋白淀粉样变性症管理的最佳实践:来自日本、巴西和葡萄牙的真实世界经验。
Orphanet J Rare Dis. 2023 Oct 12;18(1):323. doi: 10.1186/s13023-023-02910-3.